Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Mycoplasma pneumoniae pneumonia in a mouse model.
Authors: Authors: Wubbel L, Jafri HS, Olsen K, Shelton S, Barton Rogers B, Gambill G, Patel P, Keyser E, Cassell G, McCracken GH.
J Infect Dis
View full abstract on Pubmed
Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
Authors: Authors: Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR.
Pediatr Infect Dis J
View full abstract on Pubmed
Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma.
Authors: Authors: Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, Gaydos CA, Martin RJ.
Am J Respir Crit Care Med
View full abstract on Pubmed
Roles of innate and adaptive immunity in respiratory mycoplasmosis.
Authors: Authors: Cartner SC, Lindsey JR, Gibbs-Erwin J, Cassell GH, Simecka JW.
Infect Immun
View full abstract on Pubmed
Infectious causes of chronic inflammatory diseases and cancer.
Authors: Authors: Cassell GH.
Emerg Infect Dis
View full abstract on Pubmed
Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease.
Authors: Authors: Gray GC, McPhate DC, Leinonen M, Cassell GH, Deperalta EP, Putnam SD, Karcher JA, Sawyer MH, Laurila A, Connor JD.
Clin Infect Dis
View full abstract on Pubmed
Mycoplasma pulmonis inhibits electrogenic ion transport across murine tracheal epithelial cell monolayers.
Authors: Authors: Lambert LC, Trummell HQ, Singh A, Cassell GH, Bridges RJ.
Infect Immun
View full abstract on Pubmed
Preventing the misuse of microorganisms: the role of the American Society for Microbiology in protecting against biological weapons.
Authors: Authors: Berns KI, Atlas RM, Cassell G, Shoemaker J.
Crit Rev Microbiol
View full abstract on Pubmed
Emergent antibiotic resistance: health risks and economic impact.
Authors: Authors: Cassell GH.
FEMS Immunol Med Microbiol
View full abstract on Pubmed
Mycoplasma pneumoniae: a frequent cause of pneumonia among U.S. Marines in southern California.
Authors: Authors: Gray GC, Duffy LB, Paver RJ, Putnam SD, Reynolds RJ, Cassell GH.
Mil Med
View full abstract on Pubmed